 |
|
FSU researcher's 'mutant' proteins could lead to new treatment for heart disease
March 25, 2008TALLAHASSEE, Fla. -- Heart damage due to blocked arteries remains the leading cause of disease and death in the Western world, but a Florida State University College of Medicine researcher is helping to open new pathways toward treating the problem.
Michael Blaber, a professor in the department of biomedical sciences, is researching mutant forms of a human protein that have been shown to help the human body grow new blood vessels to restore blood flow in damaged areas of the heart.
Working with a $264,000, three-year grant from the American Heart Association, Blaber hopes to provide data that will enable the use of the mutant proteins in new treatment methods previously unavailable for patients with advanced "no option'' heart disease.
"This research offers the potential to treat people who currently are being sent home to die,'' Blaber said. "We've tested a group of mutants in the laboratory with unusual properties of increased stability and activities -- good properties. In some cases it was unexpected, but the results are very promising.''
Obstructed blood vessels and clogged or blocked arteries typically are treated through angioplasty, the mechanical widening of a vessel, or bypass surgery. Some patients, however, have numerous small blockages that cannot be treated through traditional approaches. In most cases, they are sent home with a predicted life expectancy that, no matter how it's phrased, sounds like a death sentence.
A new approach to the problem called therapeutic coronary angiogenesis is creating hope through the injection of human fibroblast growth factor protein into affected areas. Improvements with the procedure may arise from the use of mutant forms with increased stability.
Blaber and his research team are creating artificial "mutant'' proteins in their College of Medicine laboratory that mimic the human proteins used in angiogenic therapy, and with enhanced stability properties. So far, the mutant proteins engineered at the College of Medicine have exhibited potency in stimulating cell growth while simultaneously maintaining greater stability under conditions common to angiogenic therapy.
The work has enormous potential commercial applications and already has drawn the attention of private companies interested in the results Blaber's lab has achieved and the intellectual properties his studies are generating.
Florida State University
"This research offers the potential to treat people who currently are being sent home to die,'' Blaber said. "We've tested a group of mutants in the laboratory with unusual properties of increased stability and activities -- good properties. In some cases it was unexpected, but the results are very promising.''
Obstructed blood vessels and clogged or blocked arteries typically are treated through angioplasty, the mechanical widening of a vessel, or bypass surgery. Some patients, however, have numerous small blockages that cannot be treated through traditional approaches. In most cases, they are sent home with a predicted life expectancy that, no matter how it's phrased, sounds like a death sentence.
A new approach to the problem called therapeutic coronary angiogenesis is creating hope through the injection of human fibroblast growth factor protein into affected areas. Improvements with the procedure may arise from the use of mutant forms with increased stability.
Blaber and his research team are creating artificial "mutant'' proteins in their College of Medicine laboratory that mimic the human proteins used in angiogenic therapy, and with enhanced stability properties. So far, the mutant proteins engineered at the College of Medicine have exhibited potency in stimulating cell growth while simultaneously maintaining greater stability under conditions common to angiogenic therapy.
The work has enormous potential commercial applications and already has drawn the attention of private companies interested in the results Blaber's lab has achieved and the intellectual properties his studies are generating.
Florida State University
Heart Disease Current Events and Heart Disease News RSSMU Researchers Identify Proteins that Play Important Role in Blood Vessel Dysfunction in Type 2 Diabetes
According to the American Heart Association, three-fourths of people with diabetes die of some form of heart or blood-vessel disease.
Metabolic syndrome ups colorectal cancer risk
In a large U.S. population-based study presented at the 73rd Annual Scientific Meeting of the American College of Gastroenterology, metabolic syndrome patients had a 75 percent higher risk of colorectal cancer compared to those without metabolic syndrome.
Disease diagnosis in just 15 minutes
Testing for diseases such as cancer and multiple sclerosis could soon be as simple as using a pregnancy testing kit.
Scientists discover why a mother's high-fat diet contributes to obesity in her children
New research published online in The FASEB Journal suggests that pregnant women should think twice about high-fat foods.
Extending the life of fresh cranberries
Cranberries are tart, tiny fruits packed with powerful antioxidants. The small, red berries offer a wide variety of health benefits. Not only are cranberries a healthy, low-calorie snack, but they can also play a significant role in preventing urinary tract infections, reducing the risk of gum disease and much more.
Mental health intervention urged for heart patients
Heart patients are particularly vulnerable to depression and should be screened, and if necessary treated, to improve their recovery and overall health, according to a scientific advisory issued Monday by the American Heart Association and co-authored by a Yale School of Public Health researcher.
LIAI launches new division to look at novel approaches to heart disease and inflammation
While cholesterol-lowering drugs and new technologies have significantly advanced the nation's battle against heart disease, it continues to rank as the No. 1 killer of U.S. men and women. But if researchers at the La Jolla Institute for Allergy & Immunology (LIAI) have their way, the body's immune system will become an important player in reducing heart disease.
Researchers study how pistachios may improve heart health
Going green may be heart healthy if the green you choose is pistachio nuts, according to researchers at Penn State who conducted the first study to investigate the way pistachios lower cholesterol.
Gene variant boosts risk of fatty liver disease, scientists discover
Researchers at UT Southwestern Medical Center have found that individuals who carry a specific form of the gene PNPLA3 have more fat in their livers and a greater risk of developing liver inflammation.
Secondhand smoke linked to peripheral artery disease in women
Secondhand smoke significantly increased the risk of women developing peripheral artery disease (PAD) in a Chinese study, researchers reported in Circulation: Journal of the American Heart Association.
More Heart Disease Current Events and Heart Disease News Articles
 | Pathophysiology of Heart Disease: A Collaborative Project of Medical Students and Faculty (PATHOPHYSIOLOGY OF HEART DISEASE (LILLY)) Completely rewritten and updated for its Fourth Edition, this best-selling text is a comprehensive, clear, concise, and easy-to-understand introduction to cardiovascular diseases. It is written by internationally recognized Harvard Medical School faculty and select medical students, and is the best text to bridge basic physiology with clinical care of patients. This edition provides updated... |
 | Prevent and Reverse Heart Disease: The Revolutionary, Scientifically Proven, Nutrition-Based Cure by Caldwell B. Esselstyn A powerful call for a paradigm shift in heart disease therapy. Based on the groundbreaking results of a twenty-year nutritional study by Dr. Esselstyn, a preeminent researcher and clinician, this book illustrates that a plant-based, oil-free diet can not only prevent and stop the progression of heart disease but can also reverse its effects. The proof lies in the incredible outcomes for patients... |
 | NO More Heart Disease: How Nitric Oxide Can Prevent--Even Reverse--Heart Disease and Strokes by Louis Ignarro Dr. Louis Ignarro discovered "the atom" of cardiovascular health--a tiny molecule called Nitric Oxide. NO, as it is known by chemists, is a signaling molecule produced by the body, and is a vasodilator that helps control blood flow to every part of the body. Dr. Ignarro's findings led to the development of Viagra. Nitric Oxide has a beneficial effect on the cardiovascular system as well.NO... |
 | Reverse Heart Disease Now: Stop Deadly Cardiovascular Plaque Before It's Too Late by Sinatra, James C., M.D. Roberts While most books focus solely on the role of cholesterol in heart disease, Reverse Heart Disease Now draws on new research that points to the surprising other causes. Two leading cardiologists draw on their collective fifty years of clinical cardiology research to show you how to combine the benefits of modern medicine, over-the-counter vitamins and supplements, and simple lifestyle changes to... |
 | Dr. Dean Ornish's Program for Reversing Heart Disease by Dr Dean Ornish Dr. Dean Ornish was the first person to offer scientific proof that heart disease often can be halted or even reversed simply by changing your diet and lifestyle. Based on his internationally acclaimed scientific studies, Dr. Ornish's program yielded amazing results. Participants often reduced or discontinued medications; their chest pains usually diminished or disappeared; they felt more... |
 | Thriving With Heart Disease: The Leading Authority on the Emotional Effects of Heart Disease Tells You and Your Family How to Heal and Reclaim Your Lives by Wayne Sotile, Robin Cantor-Cooke Not only can you survive with heart disease, you can actually thrive with it -- for many, many years to come. If you are one of the 61 million Americans diagnosed with heart disease -- whether you've had a heart attack or surgery, or you have high blood pressure or angina -- you can learn how to handle its psychological side effects with the lifesaving strategies in this book. Acclaimed cardiac... |
 | Echocardiography in Congenital Heart Disease Made Simple (Cardiopulmonary Medicine from Imperial College Press) (Cardiopulmonary Medicine from Imperial College Press) by Siew Yen Ho, Michael L. Rigby, Robert Henry Anderson Congenital malformations of the heart are often dismissed as a form of complex heart disease, which is too difficult to understand, and is best referred to the specialists. The authors of this handbook, however, aim to dispel this myth. The advent of cross-sectional and, more recently, three-dimensional echocardiography, enables the structural malformations to be visualised virtually... |
 | Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine, Single Volume (Heart Disease (Braunwald) (Single Vol)) by Peter Libby, Robert O. Bonow, Douglas L. Mann, Douglas P. Zipes Dr. Braunwald's masterwork returns ... bringing you the definitive guidance you need to overcome any challenge in clinical cardiology today, using the best approaches available! Hundreds of world authorities, many of them new to this edition, synthesize all of the recent developments that are revolutionizing practice - from the newest findings in molecular biology and genetics to the latest... |
 | American Medical Association Guide to Preventing and Treating Heart Disease: Essential Information You and Your Family Need to Know about Having a Healthy Heart by American Medical Association, Martin S., MD Lipsky, Marla Mendelson, Stephen, MD, MPH Havas, Michael, MD Miller More Than 3 Million American Medical Association Books Sold. American's most trusted medical authority shows you how to prevent and treat heart disease. When you or someone you love is diagnosed with cardiovascular disease, it's important to know the facts, which can help save a life. In the American Medical Association Guide to Preventing and Treating Heart Disease, you will learn... |
 | Critical Heart Disease in Infants and Children Pediatric intensivists, cardiologists, cardiac surgeons, and anesthesiologists from the leading centers around the world present the collaborative perspectives, concepts, and state-of-the-art knowledge required to care for children with congenital and acquired heart disease in the ICU. Their multidisciplinary approach encompasses every aspect of the relevant basic scientific principles, medical... |
| © 2008 BrightSurf.com |